Jay Moyes
Direktor/Vorstandsmitglied bei BIOCARDIA INC
Vermögen: 183 505 $ am 31.05.2024
Profil
Jay M.
Moyes currently works at Puma Biotechnology, Inc., as Lead Independent Director, BioCardia, Inc., as Independent Director from 2011, Utah Association of Certified Public Accountants, as Member, and Drayton Investments LLC, as Managing Member.
Mr. Moyes also formerly worked at Osiris Therapeutics, Inc., as Independent Non-Executive Director from 2006 to 2017, SINTX Technologies, Inc., as Chief Financial Officer & Director from 2013 to 2014, Integrated Diagnostics, Inc., as Independent Director from 2011 to 2016, BioCardia, Inc., as Director, Predictive Technology Group, Inc., as Independent Director in 2019, Achieve Life Sciences, Inc., as Independent Director from 2017 to 2023, Myriad Genetics, Inc., as Chief Financial Officer from 2005 to 2007, Genmarks, Inc., as Chief Financial Officer & Vice President-Finance from 1991 to 1993, CareDx, Inc., as Chief Financial Officer from 2008 to 2009, KPMG LLP, as Senior Manager from 1979 to 1991, Utah Life Science Association, as Trustee from 1999 to 2006, and Sera Prognostics, Inc., as Chief Financial Officer & Treasurer.
Mr. Moyes received his Masters Business Admin degree from the University of Utah and undergraduate degree from Weber State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC.
0,09% | 22.04.2024 | 43 322 ( 0,09% ) | 166 790 $ | 31.05.2024 |
BIOCARDIA, INC.
0,20% | 31.03.2024 | 3 618 ( 0,20% ) | 16 715 $ | 31.05.2024 |
Aktive Positionen von Jay Moyes
| Unternehmen | Position | Beginn |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 27.04.2012 |
| BIOCARDIA INC | Direktor/Vorstandsmitglied | 01.01.2011 |
| Drayton Investments LLC | Corporate Officer/Principal | - |
| Utah Association of Certified Public Accountants | Corporate Officer/Principal | 03.06.2010 |
Ehemalige bekannte Positionen von Jay Moyes
| Unternehmen | Position | Ende |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 07.06.2023 |
| SERA PROGNOSTICS, INC. | Finanzdirektor/CFO | 07.06.2023 |
| PREDICTIVE TECHNOLOGY GROUP, INC. | Direktor/Vorstandsmitglied | 01.12.2019 |
| OSIRIS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 13.12.2017 |
Integrated Diagnostics, Inc.
 Integrated Diagnostics, Inc. Medical/Nursing ServicesHealth Services Integrated Diagnostics, Inc. operates as a molecular diagnostics firm. It develops diagnostics and measurement technologies that has a capability of measuring biomarkers for diagnosis and management of complex diseases. The company was founded by Jim Heath, David J. Galas, Leroy E. Hood, and Paul Edward Kearney and is headquartered Seattle, WA. | Direktor/Vorstandsmitglied | 01.11.2016 |
Ausbildung von Jay Moyes
| University of Utah | Masters Business Admin |
| Weber State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 8 |
|---|---|
| MYRIAD GENETICS, INC. | Health Technology |
| CAREDX, INC | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| SINTX TECHNOLOGIES, INC. | Health Technology |
| BIOCARDIA INC | Health Technology |
| ACHIEVE LIFE SCIENCES, INC. | Health Technology |
| PREDICTIVE TECHNOLOGY GROUP, INC. | Health Technology |
| SERA PROGNOSTICS, INC. | Health Services |
| Private Unternehmen | 8 |
|---|---|
| Utah Association of Certified Public Accountants | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
| Utah Life Science Association | Commercial Services |
Genmarks, Inc.
 Genmarks, Inc. Engineering & ConstructionIndustrial Services Part of Nutrien Ltd., Genmarks, Inc. is a company based in Greeley, CO. | Industrial Services |
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
BioCardia, Inc. /Old/
 BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | Health Technology |
| Drayton Investments LLC | |
Integrated Diagnostics, Inc.
Integrated Diagnostics, Inc. Medical/Nursing ServicesHealth Services Integrated Diagnostics, Inc. operates as a molecular diagnostics firm. It develops diagnostics and measurement technologies that has a capability of measuring biomarkers for diagnosis and management of complex diseases. The company was founded by Jim Heath, David J. Galas, Leroy E. Hood, and Paul Edward Kearney and is headquartered Seattle, WA. | Health Services |